1Nalesso F. Plasma filtration adsorption dialysis (PFAD): A new technology for blood purification, lnt J Artif organs, 2005,28 ( 7 ) : 731 -738.
2Bellomo R, Ronco C. Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney lnt, 1998,53 (Suppl 66 ) :S106 - 109.
3Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992,101:1644 - 1655.
5Tellez Gil LY, Rosello AM, Tones AC, et al. Modulation of soluble phases of endothelia/leukocyte adhesion molecule 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 with interleukin 1β after experimental endotoxic challenge. Crit Care Med, 2001, 29:776-781.
6Esmon CT. The protein C pathway. Crit Care Med, 2000,28:S44- 48.
7Taylor FB, Haddad PA, Hack E, et al. Two-stage response to endotoxin infusion into normal human subjects: correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response. Crit Care Med, 2001,29:326- 334.
8Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001 ;345:408 -416.
9Pinsky MR. Sepsis: a pro-and anti-inflammatory disequilibrium syndrome. Contrib Nephrol, 2001,132:354 - 366.
10Cavaillon JM, Adib-Conquy M, Cloez-Tayarani 1, et al. lmmunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon : a review. J Endotoxin Res, 2001,7 : 85 - 93.
